38 results
management treatment infections opportunistic pharmacology prevention diagnosis differential hepatology hepatitis neurology syndrome cryptococcus disease encephalitis gastroenterology meningitis mycobacterium obstetrics oncology
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals Induction therapy: • AmBd (0.7–1.0
IDSA Treatment Recommendations ... AmBd (0.7–1.0 mg ... flucytosine (100 mg ... Meningoencephalitis #IDSA ... #cryptococcus #HIVAIDS
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days) Preferred
IDSA Recommendations ... Fluconazole 100 mg ... buccal tablet 50 mg ... candida #mucosal #IDSA ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS Preventing Bacterial Enteric Illness: • Antimicrobial
IDSA Recommendations ... PO (or 400 mg IV ... PO (or 400 mg IV ... Enteric #Bacterial #IDSA ... opportunistic #infections #HIVAIDS
Classification of Tumor Lysis Syndrome (TLS) and Treatment of Metabolic Abnormalities of TLS Laboratory TLS: • Uric
Uric acid ≥ 8.0 mg ... /dL • Potassium ... ≥ 6.0 mEq/dL ... Phosphorus ≥ 4.6 mg ... ≤ 7.0 mg/dL Clinical
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Itraconazolea 200 mg ... itraconazolea 200 mg ... Penicilliosis #IDSA ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS Treating Isospora belli Infection General Management Considerations: • Fluid
IDSA Recommendations ... /800 mg) PO (or ... /800 mg) PO (or ... IsosporaBelli #IDSA ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS Treating Visceral Leishmaniasis - Preferred Therapy: •
IDSA Recommendations ... amphotericin B 2–4 mg ... schedule (e.g., 4 mg ... dose of 20–60 mg ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS Preventing Clinical Disease Indication: Individuals
IDSA Recommendations ... HIV-AIDS Preventing Clinical ... Benznidazole 5–8 mg ... Nifurtimox 8–10 mg ... opportunistic #infections #HIVAIDS
Liver Disease in Pregnancy Intrahepatic Cholestasis of Pregnancy (ICP) • Onset/Trimester: 25-32 weeks • Typical clinical features:
weeks • Typical clinical ... Bilirubin: <5 mg ... /dL • Hepatic ... Bilirubin: <5 mg ... /dL unless massive
Tumor Lysis Syndrome - Workup and Management Initial workup: BMP, Serum uric acid, LDH, Urine output, Consider
Uric acid ≥ 8 mg ... /dL • Potassium ... /dL • Calcium ... ≤ 7 mg/dL • OR ... Treatment of Clinical
No results found for "mg/dL hivaids clinical idsa"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #mg/dL #hivaids #clinical #idsa